Colgate-Palmolive Company (CL) PT Raised to $109 at UBS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall St rises as oil falls heading into US midterm elections
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts CL Hot Sheet
Price: $97.27 +2.08%
Rating Summary:
18 Buy, 15 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 21 | Down: 24 | New: 16
Rating Summary:
18 Buy, 15 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 21 | Down: 24 | New: 16
Join SI Premium – FREE
UBS analyst Peter Grom raised the price target on Colgate-Palmolive Company (NYSE: CL) to $109.00 (from $106.00) while maintaining a Buy rating.
You May Also Be Interested In
- Colgate-Palmolive Company (CL) PT Raised to $97 at TD Cowen
- Bright Minds Biosciences Inc. (DRUG) PT Lowered to $107 at Baird amid partial clinical hold
- Colgate-Palmolive Company (CL) PT Raised to $105 at BofA Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
